Work

Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma

Year: 2017

Type: article

Source: Nature

DOI: 10.1038/nature24014

Authors: Humsa S. Venkatesh, Lydia T. Tam, Pamelyn J. Woo, James Lennon, Surya Nagaraja, Shawn M. Gillespie, Jing Ni, Damien Y. Duveau, Patrick J. Morris, Jean J. Zhao, Craig J. Thomas, Michelle Monje

Institutions: Stanford Medicine, Stanford University, Harvard University, Dana-Farber Cancer Institute, National Institutes of Health, National Center for Advancing Translational Sciences, Institute for Stem Cell Biology and Regenerative Medicine

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, California Institute for Regenerative Medicine, Alex's Lemonade Stand Foundation for Childhood Cancer, Cure Starts Now Foundation, National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G134922848, G2105180758, G3205814483, A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3, Neuronal activity-regulated mechanisms of glioma growth, White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain”, G8265313742, G9000096124, Stanford Cancer Institute, Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer, Targeted Therapies for Glioma, Integrating targeted therapy and immunotherapy to break through cancer

OpenAlex ID: W2758553652

FWCI: 21.26

Cites: 54

Cited by: 607

Related to: 10